People · Operator

Joseph C McNay

Named in public records as an officer, director or promoter · active 2011–2016 · Pharmaceuticals

1
Companies
4
Filings
$19.8M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Regenerx Biopharmaceuticals IncPharmaceuticalsSeries A$19.8M$40.3M2011
Operator network

Joseph C McNay at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Allan Goldstein · 2 companies · 1 sharedAllan GoldsteinC Neil Lyons · 2 companies · 1 sharedC Neil LyonsJoseph McNay · 2 companies · 1 sharedJoseph McNayMauro Bove · 2 companies · 1 sharedMauro BoveR Don Elsey · 2 companies · 1 sharedR Don ElseyAllan L Goldstein · 1 companies · 1 sharedAllan L GoldsteinDavid Crockford · 1 companies · 1 sharedDavid CrockfordJ.J. Finkelstein · 1 companies · 1 sharedJ.J. FinkelsteinJoseph Don McNay · 1 companies · 1 sharedJoseph Don McNayJospeh McNay · 1 companies · 1 sharedJospeh McNayL. Thompson Bowles · 1 companies · 1 sharedL. Thompson BowlesL. THOMPSON L. BOWLES · 1 companies · 1 sharedL. THOMPSON L. BO…Mauro L Bove · 1 companies · 1 sharedMauro L BoveR. DON L. ELSEY · 1 companies · 1 sharedR. DON L. ELSEYRichard Hindin · 1 companies · 1 sharedRichard HindinRegenerx Biopharmaceuticals Inc · $19.8M raisedRegenerx Biopharmaceu…Joseph C McNayJM
Joseph C McNay Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Joseph C McNay on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
C Neil Lyons12
Allan Goldstein12
Mauro Bove12
R Don Elsey12
Joseph McNay12
Jospeh McNay11
Allan L Goldstein11
Mauro L Bove11
R. DON L. ELSEY11
L. THOMPSON L. BOWLES11
Joseph Don McNay11
Richard Hindin11
David Crockford11
L. Thompson Bowles11
J.J. Finkelstein11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.